NVG-291
N/A
Report date: 2023/08/04 19:31:04
NME
Base Information
Drug NameNVG-291
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNervGen Pharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesNervGen Pharma Corp
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A